CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C16404 | BRD-K43992612 | BRD-K43992612 | -- | -- | -- | Details |
| C16405 | BRD-K44003352 | BRD-K44003352 | -- | -- | -- | Details |
| C16406 | BRD-K44004064 | acefylline | ADORA1 | Adenosine receptor agonist | -- | Details |
| C16407 | BRD-K44004565 | BRD-K44004565 | -- | -- | -- | Details |
| C16408 | BRD-K44007425 | BRD-K44007425 | -- | -- | -- | Details |
| C16409 | BRD-K44011183 | BRD-K44011183 | -- | -- | -- | Details |
| C16410 | BRD-K44012257 | BRD-K44012257 | -- | -- | -- | Details |
| C16411 | BRD-K44012584 | BRD-K44012584 | -- | -- | -- | Details |
| C16412 | BRD-K44015831 | BRD-K44015831 | -- | -- | -- | Details |
| C16413 | BRD-K44021875 | BRD-K44021875 | -- | -- | -- | Details |
| C16414 | BRD-K44026015 | BRD-K44026015 | -- | -- | -- | Details |
| C16415 | BRD-K44027058 | BRD-K44027058 | -- | -- | -- | Details |
| C16416 | BRD-K44029733 | BRD-K44029733 | -- | -- | -- | Details |
| C16417 | BRD-K44029853 | BRD-K44029853 | -- | -- | -- | Details |
| C16418 | BRD-K44036769 | BRD-K44036769 | -- | -- | -- | Details |
| C16419 | BRD-K44042747 | BRD-K44042747 | -- | -- | -- | Details |
| C16420 | BRD-K44052748 | BRD-K44052748 | -- | -- | -- | Details |
| C16421 | BRD-K44061011 | BRD-K44061011 | -- | -- | -- | Details |
| C16422 | BRD-K44062658 | BRD-K44062658 | -- | -- | -- | Details |
| C16423 | BRD-K44067360 | flufenamic-acid | AR; PTGS1; PTGS2; AKR1C3 | Chloride channel antagonist | -- | Details |
| C16424 | BRD-K44070326 | BRD-K44070326 | -- | -- | -- | Details |
| C16425 | BRD-K44078665 | BRD-K44078665 | -- | -- | -- | Details |
| C16426 | BRD-K44079161 | BRD-K44079161 | -- | -- | -- | Details |
| C16427 | BRD-K44080306 | BRD-K44080306 | -- | -- | -- | Details |
| C16428 | BRD-K44084986 | Y-27632 | ROCK1; ROCK2 | Rho associated kinase inhibitor | -- | Details |
| C16429 | BRD-K44086628 | BRD-K44086628 | -- | -- | -- | Details |
| C16430 | BRD-K44094313 | mifepristone | NR3C1; AR; PGR | Progesterone receptor antagonist; Glucocorticoid receptor antagonist | -- | Details |
| C16431 | BRD-K44094599 | tacrolimus | FKBP1A | Calcineurin inhibitor | -- | Details |
| C16432 | BRD-K44097254 | BRD-K44097254 | -- | -- | -- | Details |
| C16433 | BRD-K44098776 | BRD-K44098776 | -- | -- | -- | Details |
| C16434 | BRD-K44100512 | KIN001-043 | -- | -- | -- | Details |
| C16435 | BRD-K44103530 | BRD-K44103530 | -- | -- | -- | Details |
| C16436 | BRD-K44104823 | BRD-K44104823 | -- | -- | -- | Details |
| C16437 | BRD-K44119437 | BRD-K44119437 | -- | -- | -- | Details |
| C16438 | BRD-K44121468 | BRD-K44121468 | -- | -- | -- | Details |
| C16439 | BRD-K44123761 | BRD-K44123761 | -- | -- | -- | Details |
| C16440 | BRD-K44126416 | BRD-K44126416 | -- | -- | -- | Details |
| C16441 | BRD-K44131977 | BRD-K44131977 | -- | -- | -- | Details |
| C16442 | BRD-K44133102 | BRD-K44133102 | -- | -- | -- | Details |
| C16443 | BRD-K44133266 | sulbactam | -- | -- | -- | Details |
| C16444 | BRD-K44134539 | BRD-K44134539 | -- | -- | -- | Details |
| C16445 | BRD-K44136596 | HTS-12264SC | -- | -- | -- | Details |
| C16446 | BRD-K44139185 | BRD-K44139185 | -- | -- | -- | Details |
| C16447 | BRD-K44139682 | BRD-K44139682 | -- | -- | -- | Details |
| C16448 | BRD-K44141416 | BRD-K44141416 | -- | -- | -- | Details |
| C16449 | BRD-K44150994 | BRD-K44150994 | -- | -- | -- | Details |
| C16450 | BRD-K44152881 | BRD-K44152881 | -- | -- | -- | Details |
| C16451 | BRD-K44161636 | BRD-K44161636 | -- | -- | -- | Details |
| C16452 | BRD-K44167510 | BRD-K44167510 | -- | -- | -- | Details |
| C16453 | BRD-K44177046 | BRD-K44177046 | -- | -- | -- | Details |
| C16454 | BRD-K44177822 | BRD-K44177822 | -- | -- | -- | Details |
| C16455 | BRD-K44193634 | BRD-K44193634 | -- | -- | -- | Details |
| C16456 | BRD-K44194212 | BRD-K44194212 | -- | -- | -- | Details |
| C16457 | BRD-K44194970 | BRD-K44194970 | -- | -- | -- | Details |
| C16458 | BRD-K44196287 | chlorobenzene | -- | -- | -- | Details |
| C16459 | BRD-K44200196 | BRD-K44200196 | -- | -- | -- | Details |
| C16460 | BRD-K44203030 | BRD-K44203030 | -- | -- | -- | Details |
| C16461 | BRD-K44204252 | BRD-K44204252 | -- | -- | -- | Details |
| C16462 | BRD-K44204702 | BRD-K44204702 | -- | -- | -- | Details |
| C16463 | BRD-K44205194 | BRD-K44205194 | -- | -- | -- | Details |
| C16464 | BRD-K44207800 | BRD-K44207800 | -- | -- | -- | Details |
| C16465 | BRD-K44212150 | BRD-K44212150 | -- | -- | -- | Details |
| C16466 | BRD-K44214276 | BRD-K44214276 | -- | -- | -- | Details |
| C16467 | BRD-K44218044 | BRD-K44218044 | -- | -- | -- | Details |
| C16468 | BRD-K44218307 | BRD-K44218307 | -- | -- | -- | Details |
| C16469 | BRD-K44218819 | tryptamine | -- | -- | -- | Details |
| C16470 | BRD-K44224150 | BRD-K44224150 | -- | -- | -- | Details |
| C16471 | BRD-K44225498 | BRD-K44225498 | -- | -- | -- | Details |
| C16472 | BRD-K44227013 | ponatinib | FGFR1; FGFR3; FGFR2; FGFR4; FLT3; ABL1; KIT; RET; BCR; TEK | FLT3 inhibitor; PDGFR inhibitor; Abl kinase inhibitor | -- | Details |
| C16473 | BRD-K44229115 | BRD-K44229115 | -- | -- | -- | Details |
| C16474 | BRD-K44235509 | BRD-K44235509 | -- | -- | -- | Details |
| C16475 | BRD-K44236678 | BRD-K44236678 | -- | -- | -- | Details |
| C16476 | BRD-K44238634 | BRD-K44238634 | -- | -- | -- | Details |
| C16477 | BRD-K44241590 | ASN-05257430 | -- | -- | -- | Details |
| C16478 | BRD-K44242139 | BRD-K44242139 | -- | -- | -- | Details |
| C16479 | BRD-K44244207 | BRD-K44244207 | -- | -- | -- | Details |
| C16480 | BRD-K44245916 | BRD-K44245916 | -- | -- | -- | Details |
| C16481 | BRD-K44252324 | BRD-K44252324 | -- | -- | -- | Details |
| C16482 | BRD-K44256916 | BRD-K44256916 | -- | -- | -- | Details |
| C16483 | BRD-K44258506 | BRD-K44258506 | -- | -- | -- | Details |
| C16484 | BRD-K44260904 | BRD-K44260904 | -- | -- | -- | Details |
| C16485 | BRD-K44261129 | BRD-K44261129 | -- | -- | -- | Details |
| C16486 | BRD-K44265418 | BRD-K44265418 | -- | -- | -- | Details |
| C16487 | BRD-K44266302 | BRD-K44266302 | -- | -- | -- | Details |
| C16488 | BRD-K44273375 | tolnaftate | -- | -- | -- | Details |
| C16489 | BRD-K44276885 | acarbose | GAA; AMY2A; MGAM | Glucosidase inhibitor | -- | Details |
| C16490 | BRD-K44284819 | p-cresidine | -- | -- | -- | Details |
| C16491 | BRD-K44287054 | BRD-K44287054 | -- | -- | -- | Details |
| C16492 | BRD-K44289311 | BRD-K44289311 | -- | -- | -- | Details |
| C16493 | BRD-K44292107 | BRD-K44292107 | -- | -- | -- | Details |
| C16494 | BRD-K44298652 | BRD-K44298652 | -- | -- | -- | Details |
| C16495 | BRD-K44302407 | BRD-K44302407 | -- | -- | -- | Details |
| C16496 | BRD-K44304623 | BRD-K44304623 | -- | -- | -- | Details |
| C16497 | BRD-K44307624 | BRD-K44307624 | -- | -- | -- | Details |
| C16498 | BRD-K44309337 | BRD-K44309337 | -- | -- | -- | Details |
| C16499 | BRD-K44309363 | dexniguldipine | -- | -- | -- | Details |
| C16500 | BRD-K44316554 | BRD-K44316554 | -- | -- | -- | Details |
| C16501 | BRD-K44320761 | BRD-K44320761 | -- | -- | -- | Details |
| C16502 | BRD-K44328896 | BRD-K44328896 | -- | -- | -- | Details |
| C16503 | BRD-K44338067 | BRD-K44338067 | -- | -- | -- | Details |